Results 21 to 30 of about 548 (135)

Renal Involvement in Antiphospholipid Syndrome

Frontiers in Immunology, 2018
Antiphospholipid syndrome is a complex autoimmune disease, characterized by the presence of vascular thrombosis, obstetric, hematologic, cutaneous, and cardiac manifestations. Renal disease in patients with antiphospholipid syndrome was not recognized in
Alonso Turrent-Carriles, Juan Pablo Herrera-Félix, Mary-Carmen Amigo   +2 more
doaj   +1 more source

Primary antiphospholipid syndrome in pediatrics: beyond thrombosis. Report of 32 cases and review of the evidence

Pediatric Rheumatology Online Journal, 2022
Objective Describe the frequency of thrombotic and non-thrombotic clinical manifestations, laboratory, treatment and prognosis in patients with pediatric primary antiphospholipid syndrome.
Alfonso-Ragnar Torres-Jimenez, Virginia Ramirez-Nova, Adriana Ivonne Cespedes-Cruz, Berenice Sanchez-Jara, Alejandra Velazquez-Cruz, Vilma Carolina Bekker-Méndez, Francisco Xavier Guerra-Castillo   +6 more
doaj   +1 more source

Primary antiphospholipid syndrome presenting as antiphospholipid syndrome nephropathy: a case report

Journal of Medical Case Reports, 2015
Primary antiphospholipid syndrome can be a difficult diagnosis in the absence of typical clinical features. We describe an unusual presentation of primary antiphospholipid syndrome mimicking vasculitis for which the only diagnostic clue on initial presentation was antiphospholipid syndrome nephropathy.A 29-year-old Sri Lankan woman presented with ...
Abeysekera, Rajitha Asanga, Wazil, Abdul Wahid Mohomad, Nanayakkara, Nishantha, Ratnatunga, Neelakanthi VI, Fernando, Kaushal Maithree, Thinnarachchi, Jalitha   +5 more
openaire   +2 more sources

Antiphospholipid Syndrome and the Kidney

Kidney International Reports
Antiphospholipid syndrome (APS) is a rare autoimmune disorder characterized by the persistent positivity of antiphospholipid antibodies (aPLs) along with thrombotic manifestations, obstetrical complications, or nonthrombotic manifestations. The kidney is
Maxime Taghavi, Lucas Jacobs, Dario Roccatello, Savino Sciascia   +3 more
doaj   +1 more source

Síndrome antifosfolípide Antiphospholipid syndrome

Anais Brasileiros de Dermatologia, 2005
Condição adquirida, sistêmica, caracterizada por tromboses recorrentes no sistema arterial, venoso ou ambos, a síndrome antifosfolípide pode ser primária ou secundária, esta última mais associada ao lúpus eritematoso sistêmico e menos freqüentemente a ...
Jesus Rodriguez Santamaria, Daniela Badziak, Michelle Ferreira de Barros, Fernando Luiz Mandelli, Leila Cristina Cavalin, Maurício Shigueru Sato   +5 more
doaj   +1 more source

Building a Framework for Sexual and Reproductive Health Care in the Rheumatology Context: Content and Approaches

Arthritis Care &Research, EarlyView.
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley   +1 more source

Multiorgan catastrophic antiphospholipid syndrome with histopathologic confirmation: from crisis to recovery [PDF]

Romanian Journal of Rheumatology
Catastrophic antiphospholipid syndrome (CAPS) is a rare, life-threatening variant of antiphospholipid syndrome characterized by rapid-onset thrombosis in multiple vascular beds, leading to multiorgan failure. Despite its high mortality, early recognition
Ana Paiva Santos, Pedro Teixeira, Inês Almeida Pintor, Pedro Lopes, Lina Carvalho   +4 more
doaj   +1 more source

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

Arthritis Care &Research, EarlyView.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci, Megan R. W. Barber, Ann E. Clarke, Sindhu R. Johnson, Anselm Mak, Hermine I. Brunner, Murat Inanc, Rosalind Ramsey‐Goldman, Guillermo Ruiz‐Irastorza, Ellen M. Ginzler, John G. Hanly, Alexandra Legge, Cynthia Aranow, Laurent Arnaud, Nathalie Costedoat‐Chalumeau, Dafna D. Gladman, Søren Jacobsen, Michelle Petri, Clovis A. Silva, Évelyne Vinet, Alexandre E. Voskuyl, SDI Revision Literature Review Groups, SDI Revision Delphi Panel, SDI Revision Item Reduction Committee, SDI Revision Clinical Domain Groups, Ian N. Bruce   +25 more
wiley   +1 more source

Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid Syndrome

Case Reports in Hematology, 2018
Catastrophic antiphospholipid syndrome is a rare condition with high morbidity and mortality. We present a refractory case of catastrophic antiphospholipid syndrome with a view to highlight the importance of early identification and aggressive treatment ...
Karthik Nath, Andrew McCann
doaj   +1 more source

Antiphospholipid Syndrome and Kidney Involvement: New Insights

Antibodies, 2016
Antiphospholipid syndrome is an autoimmune disorder characterized by vascular thromboses and pregnancy morbidity associated with antiphospholipid antibodies: lupus anticoagulant, IgG or IgM anticardiolipin or anti-beta 2-glycoprotein I. The kidney is one
José A. Martínez-Flores, Manuel Serrano, Jose M. Morales, Antonio Serrano   +3 more
doaj   +1 more source